20-F: Medirom Healthcare Technologies Inc. Reports Fiscal Year 2024 Results, Navigates Challenges and Pursues Strategic Growth

Medirom Healthcare Technologies Inc. files its annual report, detailing its financial performance for the year ended December 31, 2024, while addressing going concern uncertainties and outlining strategic initiatives for future growth.

Summary

• Medirom Healthcare Technologies Inc. reported its financial results for the fiscal year ended December 31, 2024.
• The company's revenue increased by 21.5% to JPY8,299 million compared to JPY6,828 million in the previous year.
• The Relaxation Salon Segment remains the core business, contributing 89.7% of total revenue.
• The Digital Preventative Healthcare Segment experienced a revenue decrease, attributed to temporary shipment suspensions due to technological issues.
• The company is actively pursuing strategic initiatives, including workforce optimization, expansion of spa facility salons, and targeted acquisitions.
• Medirom is addressing going concern uncertainties by exploring additional capital raising and cost reduction measures.
• The company plans to acquire 70% of Japan Gene Medicine Corporation, aiming to expand its presence in the healthcare technology space.
• The company is working to improve ZACCs financial performance through efforts to hire additional talented assistants who have the potential to become top stylists and train current stylists to better promote their services via social networking services such as Instagram.
• The company is also working to enhance its digital marketing initiatives, including through our smart phone apps, to retain our repeat customers and improve the frequency of customer visits.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there is revenue growth and strategic initiatives are underway, there are also significant challenges related to going concern, internal controls, and regulatory compliance.

Positives

• Overall revenue growth of 21.5% indicates positive business momentum.
• Strategic initiatives, such as workforce optimization and targeted acquisitions, aim to improve profitability.
• Expansion into the Digital Preventative Healthcare Segment and the Luxury Beauty Segment diversifies revenue streams.
• The planned acquisition of Japan Gene Medicine Corporation presents opportunities for growth in the healthcare technology space.
• The company is working to improve ZACCs financial performance through efforts to hire additional talented assistants who have the potential to become top stylists and train current stylists to better promote their services via social networking services such as Instagram.
• The company is also working to enhance its digital marketing initiatives, including through our smart phone apps, to retain our repeat customers and improve the frequency of customer visits.

Negatives

• The Digital Preventative Healthcare Segment experienced a revenue decrease due to technological issues.
• The company faces going concern uncertainties due to working capital deficiency and negative cash flows from operations.
• The company has identified material weaknesses in its internal control over financial reporting.
• The company is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on The Nasdaq Capital Market.

Risks

• The company may not be able to achieve its development goals, which could adversely affect its operations and financial results.
• The company is implementing new growth strategies, priorities and initiatives and any inability to execute and evolve its strategy over time could adversely impact its financial condition and results of operations.
• The company's planned acquisition of Japan Gene Medicine Corporation may not be completed on a timely basis, on its anticipated terms, or at all, and there are uncertainties and risks to consummating the acquisition and integrating the acquired business.
• The company may need to raise additional capital to meet its business requirements in the future, and such capital raising may be costly or difficult to obtain and could dilute current shareholders ownership interests.
• The company's level of indebtedness could materially and adversely affect its business, financial condition and results of operations.
• The company is vulnerable to changes in consumer preferences and economic conditions that could harm its business, financial condition, results of operations and cash flow.
• The company may not be able to compete successfully with other relaxation salon businesses, which could materially and adversely affect its results of operations.
• The company faces significant competition and continuous technological change.
• Information technology system failures or breaches of the company's network security could interrupt its operations and adversely affect its business.
• The requirements of being a U.S. public company may strain the company's resources and divert management's attention.
• The company has identified material weaknesses in its internal control over financial reporting. If the company fails to maintain an effective system of internal control to remediate its material weakness over financial reporting, it may be unable to accurately report its results of operations, meet its reporting obligations or prevent fraud.
• The company cannot assure you that the ADSs will remain liquid or that they will remain listed on NASDAQ.
• The price of the ADSs may fluctuate substantially.
• Sales of a substantial number of the company's common shares or ADSs in the public markets by its existing shareholders in the future could cause the price of the ADSs to fall.
• The future issuance of additional common shares in connection with the company's stock option plan, convertible bonds, acquisitions or otherwise may adversely affect the market of the ADSs.
• The right of holders of ADSs to participate in any future rights offerings may be limited, especially with respect to offerings other than distributions of cash, which may cause dilution to their holdings and holders of ADSs may not receive cash dividends if it is impractical to make them available to them.
• ADS holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable outcomes to the plaintiff(s) in any such action.
• The company is incorporated in Japan, and it may be more difficult to enforce judgments against us that are obtained in courts outside of Japan.
• Substantially all of the company's revenues are generated in Japan, but an increase of its international presence could expose it to fluctuations in foreign currency exchange rates, or a change in monetary policy may harm its financial results.
• Third party claims with respect to intellectual property assets, if decided against the company, may result in competing uses or require adoption of new, non-infringing intellectual property, which may in turn adversely affect sales and revenues.
• Changes in regulatory requirements, or in application of current regulatory requirements, may have an adverse effect on the company's business and results of operations.
• Matters relating to employment and labor law may adversely affect the company's business.
• If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about the company's business, the price of the ADSs and trading volume could decline.

Future Outlook

The company aims to operate 500 salons by the end of 2028 and is focused on expanding its Digital Preventative Healthcare Segment. The company is also planning to acquire 70% of the equity of Japan Gene Medicine Corporation.

Industry Context

The Japanese relaxation sector is experiencing consolidation, with market share shifting towards category leaders. The sector is expected to outpace overall GDP growth, driven by increasing consumer interest in health and wellness.

Comparison to Industry Standards

• According to the 2022 Yano Report, Medirom is one of the top three companies in terms of the number of salons in the Kanto region and in the top four nationwide.
• The largest operator in the Japanese relaxation sector has 613 salons, while Medirom had 308 salons as of December 31, 2024.
• The company's MOTHER Bracelet is described as the only fitness tracker that requires no electric charging, giving it a unique selling point.
• According to a 2024 research report prepared by SDKI Analytics (the SDKI Report), a Japanese market research company, only approximately 3.5% of pregnant women in Japan receive NIPT tests, as compared to 28-50%, 30%, 51%, and 75% in the United States, Germany, the Netherlands, and Belgium, respectively.

Related Party Transactions

• Kouji Eguchi, the company's founder and Chief Executive Officer, is a guarantor for five bank loans on behalf of the company.
• Tomoya Ogawa, an independent director of the company, is the sole owner of Kabushiki Kaisha LTW, which received consulting fees from the company.
• Akira Nojima, an independent director of the company, is the sole owner of Kabushiki Kaisha No Track, which received consulting fees from the company.
• Osamu Sato, a corporate auditor of the company, is a part-time employee of Ebis 20 Co., Ltd., which received consulting fees from the company.
• Kazuyoshi Takahashi, the representative director of ZACC, is the guarantor for three bank loans on behalf of ZACC.
• On December 11, 2024, Issei Homan, Chief Technology Officer of MEDIROM MOTHER Labs Inc., and Yasuhiro Hayami, Chief Business Officer of MML, invested 45,000 thousand and 5,040 thousand, respectively, in MMLs Series A financing.
• On July 31, 2024, COZY LLC (COZY), a company owned and controlled by Mr. Eguchi, who is the controlling shareholder of our Company, entered into share purchase agreements with two shareholders of our common shares for the purchase of an aggregate of 25,000 common shares (representing a total purchase price of approximately JPY50 million), effective July 31, 2024.

Stakeholder Impact

• Shareholders face potential dilution from future equity offerings.
• Employees may be affected by workforce optimization strategies.
• Customers may experience changes in service offerings and pricing.
• Franchisees may be impacted by changes in franchise agreements and support.

Next Steps

• The company will continue to implement measures to remediate the material weaknesses identified in its internal control over financial reporting.
• The company will monitor the bid price of its American Depositary Shares and may consider implementing available measures to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules.
• The company will continue to seek attractive financing opportunities for its Digital Preventative Healthcare business, and may seek to raise additional capital to aggressively expand the business.
• The company will continue to negotiate the terms of its bank loan financing with financial institutions for the planned acquisition of Japan Gene Medicine Corporation.

Key Dates

Keywords

financial results, annual report, healthcare, relaxation salons, digital preventative healthcare, luxury beauty, Japan, MEDIROM